Literature DB >> 2788161

Glutathione regulates interleukin-2 activity on cytotoxic T-cells.

C M Liang1, N Lee, D Cattell, S M Liang.   

Abstract

In this study, we examined whether and how the cellular activity of interleukin-2 (IL-2) is affected by glutathione (GSH), an important tripeptide existing in most cells. Cell culture and thymidine incorporation assay showed that addition of GSH enhanced the effect of IL-2 on the proliferation and thymidine incorporation of IL-2-dependent cytotoxic T-cells such as CTLL-2 and CT-4R. Treatment of the cells with GSH resulted in a 2-fold increase in the amount of IL-2 bound to the cells and a rapid internalization of the bound IL-2. In addition, the degradation of IL-2 in the cells was enhanced by GSH treatment. These effects of GSH were accompanied by an increase in the intracellular GSH level. L-Buthionine-(S,R)-sulfoximine, an inhibitor of de novo GSH synthesis, blunted the increase of intracellular GSH level and modulated the effect of GSH on IL-2 activity. These results suggest that GSH regulates the binding, internalization, degradation, and T-cell proliferative activity of IL-2; alterations of cellular GSH concentration may thus affect the growth and replication of IL-2-sensitive cytotoxic T-cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788161

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  The ROOT MERISTEMLESS1/CADMIUM SENSITIVE2 gene defines a glutathione-dependent pathway involved in initiation and maintenance of cell division during postembryonic root development.

Authors:  T Vernoux; R C Wilson; K A Seeley; J P Reichheld; S Muroy; S Brown; S C Maughan; C S Cobbett; M Van Montagu; D Inzé; M J May; Z R Sung
Journal:  Plant Cell       Date:  2000-01       Impact factor: 11.277

2.  Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases.

Authors:  I L Chapple
Journal:  Clin Mol Pathol       Date:  1996-10

3.  Regulation by glutathione of interleukin-4 activity on cytotoxic T cells.

Authors:  S M Liang; N Lee; D S Finbloom; C M Liang
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

4.  Involvement of gamma-glutamyl peptides in osmoadaptation of Escherichia coli.

Authors:  D McLaggan; T M Logan; D G Lynn; W Epstein
Journal:  J Bacteriol       Date:  1990-07       Impact factor: 3.490

Review 5.  The glutathione system: a new drug target in neuroimmune disorders.

Authors:  Gerwyn Morris; George Anderson; Olivia Dean; Michael Berk; Piotr Galecki; Marta Martin-Subero; Michael Maes
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

6.  Selective regulation of CD40 expression in murine dendritic cells by thiol antioxidants.

Authors:  Norifumi Iijima; Yoshiki Yanagawa; Kazuya Iwabuchi; Kazunori Onoé
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

7.  Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.

Authors:  R Buhl; C Vogelmeier; M Critenden; R C Hubbard; R F Hoyt; E M Wilson; A M Cantin; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione.

Authors:  A C Miller; J Gafner; E P Clark; D Samid
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

9.  Costs and benefits of experimentally induced changes in the allocation of growth versus immune function under differential exposure to ectoparasites.

Authors:  Natalia Pitala; Heli Siitari; Lars Gustafsson; Jon E Brommer
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

10.  Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function.

Authors:  R Sinha; I Sinha; A Calcagnotto; N Trushin; J S Haley; T D Schell; J P Richie
Journal:  Eur J Clin Nutr       Date:  2017-08-30       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.